Microchimerism: Incidental byproduct of pregnancy or active participant in human health?

Trends in Molecular Medicine

Volumn 8, Issue 3, 2002, Pages 109-113

  Nelson, J Lee ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BLOOD TRANSFUSION; CIRCULATION; FETOPLACENTAL UNIT; HEALTH; HLA SYSTEM; HUMAN; MICROCHIMERISM; PATHOGENESIS; PREGNANCY; REVIEW;

ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; CHIMERA; FEMALE; HEALTH; HLA ANTIGENS; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0036090777     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02269-9     Document Type: Review

References (43)

1. Quantitative analysis of the bi-directional fetomaternal transfer of nucleated cells and plasma DNA
2. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
3. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: Comparison with Sjögren syndrome and scleroderma
4. Maternal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune?
5. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization
6. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification
7. Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy
8. Microchimerism of maternal origin persists into adult life
9. A new case of human chimerism detected after pregnancy: 46,XY karyotype in the lymphocytes of a woman
10. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients. Frequent long-term microchimerism in severe trauma patients
11. Significant fetal-maternal hemorrhage after termination of pregnancy: Implications for development of fetal cell microchimerism
12. Microchimerism and HLA-compatible relationships of pregnancy in SSc
13. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease
14. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
15. Microchimerism and autoimmune disease
16. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma
17. Microchimerism in Japanese women patients with systemic sclerosis
18. Y chromosome microchimeris in rheumatic autoimmune disease
19. Microchimerism in Japanese patients with systemic sclerosis
20. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens
21. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride
22. Fetal cell microchimerism in multiple tissues from multiple sites in women with systemic sclerosis
23. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis
24. Fetal microchimerism in primary biliary cirrhosis
25. Blood fetal microchimerism in primary biliary cirrhosis
26. FISH for Y chromosome in women with primary biliary cirrhosis: Lack of evidence for leukocyte microchimerism
27. Detection of male DNA in the liver of female patients with primary biliary cirrhosis
28. Evidence of fetal microchimerism in Hashimoto's thyroiditis
29. Microchimerism of presumed fetal origin in adult female thyroid specimens
30. Fetal DNA in skin of polymorphic eruptions of pregnancy
31. Microchimerism in a female patient with systemic lupus erythematosus
32. Lack of evidence for an increased microchimerism in the circulation of patient with Sjogren's syndrome
33. Chimerism and autoimmunity
34. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation
35. Neonatal lupus
36. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis
37. HLA DQA1*0501 is associated with diffuse systemic sclerosis in men
38. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies
39. Chimerism in children with juvenile dermatomyositis
40. The immune system: Effector and target of graft-versus-host disease
41. + cells in MHC class I plus II different host
42. Role of indirect allorecognition in allograft rejection
43. The veto phenomenon and T-cell regulation